Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 71.90 INR
Change Today -0.95 / -1.30%
Volume 1.9K
MAKR On Other Exchanges
Symbol
Exchange
Mumbai
As of 6:21 AM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

makers laboratories ltd (MAKR) Snapshot

Open
74.00
Previous Close
72.85
Day High
74.00
Day Low
69.50
52 Week High
04/16/15 - 87.95
52 Week Low
11/7/14 - 29.25
Market Cap
353.5M
Average Volume 10 Days
12.5K
EPS TTM
4.78
Shares Outstanding
4.9M
EX-Date
07/28/15
P/E TM
15.0x
Dividend
1.00
Dividend Yield
1.39%
Current Stock Chart for MAKERS LABORATORIES LTD (MAKR)

Related News

No related news articles were found.

makers laboratories ltd (MAKR) Related Businessweek News

No Related Businessweek News Found

makers laboratories ltd (MAKR) Details

Makers Laboratories Limited engages in the manufacture and sale of pharmaceutical products in India. The company offers products in various general health therapeutic segments, including antibiotic, anti–inflammatory, analgesic, antispasmodic, cough and cold control, cardio-diabetic, anti-allergic, acid regulatory, anthelmintic, topical antibiotic/antimicrobial, neurotonic, anti-anxiety, tranquiliser, anti-malarial, anti-fungal, anti-emetics and anti-nauseants, anti-diarrhoeal, nutritional, injectable, and other specialties. It offers various formulations, including paracetamol, a-ß arteether, chloroquine, nimuselide, anti cough, and amoxicillin under the Duramol, Loroquin, Artemak-AB, Nimuwin, Cofwin, and Exylin brand names. It serves stockists, doctors, and retailers. The company was incorporated in 1984 and is based in Mumbai, India.

140 Employees
Last Reported Date: 05/29/15
Founded in 1984

makers laboratories ltd (MAKR) Top Compensated Officers

Chief Executive Officer, Whole Time Director,...
Total Annual Compensation: 3.0M
Compliance Officer, Company Secretary and Mem...
Total Annual Compensation: 491.4K
General Manager of Quality Assurance, Wholeti...
Total Annual Compensation: 2.4M
Compensation as of Fiscal Year 2015.

makers laboratories ltd (MAKR) Key Developments

Makers Laboratories Ltd Recommends Dividend for the Financial Year Ended March 31, 2015

Makers Laboratories Ltd. announced that the Board of Directors of the company at its meeting held on May 29, 2015, the Board has recommended a dividend of INR 1 per share (10%) for the financial year ended March 31, 2015.

Makers Laboratories Limited Announces Audited Standalone Earnings Results for the Fourth Quarter and Year Ended March 31, 2015

Makers Laboratories Limited announced audited standalone earnings results for the fourth quarter and year ended March 31, 2015. For the quarter, on a standalone basis, the company reported net sales/income from operations of INR 138.133 million compared to INR 165.169 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 3.328 million compared to loss from operations before other income, finance costs and exceptional items of INR 5.864 million a year ago. Profit from ordinary activities before tax was INR 3.951 million compared to loss from ordinary activities before tax of INR 4.844 million a year ago. Net profit was INR 2.884 million compared to net loss of INR 4.621 million a year ago. Basic and diluted EPS before and after extraordinary items was INR 0.61 compared to basic and diluted LPS before and after extraordinary items of INR 0.94 a year ago. For the year, on a standalone basis, the company reported net sales/income from operations of INR 647.027 million compared to INR 663.156 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 26.008 million compared to INR 10.691 million a year ago. Profit from ordinary activities before tax was INR 33.989 million compared to INR 11.875 million a year ago. Net profit was INR 23.519 million compared to INR 5.856 million a year ago. Basic and diluted EPS after extraordinary items was INR 4.78 compared to basic and diluted LPS before and after extraordinary items of INR 1.21 a year ago.

Makers Laboratories Limited to Report Fiscal Year 2015 Results on May 29, 2015

Makers Laboratories Limited announced that they will report fiscal year 2015 results on May 29, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MAKR:IN 71.90 INR -0.95

MAKR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MAKR.
View Industry Companies
 

Industry Analysis

MAKR

Industry Average

Valuation MAKR Industry Range
Price/Earnings 14.6x
Price/Sales 0.5x
Price/Book 1.4x
Price/Cash Flow 8.9x
TEV/Sales 0.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MAKERS LABORATORIES LTD, please visit www.makerslabs.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.